Search results for "biotech"

Article A Bright Future for the Plasma Fractionation Industry
That was one of the conclusions reached when the 9th Plasma Product Biotechnology (PPB) meeting ended on the beautiful island of Sardinia, Italy in mid-May. This meeting series, which is a joint organ…

Article Tackling Analytical Method Development for ADCs
… both fields to forge integrated techniques that will bridge the knowledge gap and blend pharma and biotech platforms, and the interface of these analytical techniques allows real understanding of th…

Article Improving PAT for Biologics
…rio Becker, director of marketing and product management for PAT and automation at Sartorius Stedim Biotech. Because bioprocesses are complex and dependent on multi-factor interactions between the…

Article Trends in Single-use Bioreactors
…bsp;Cytiva; and Mikel Sherman, global product manager of single-use bioreactors at Sartorius Stedim Biotech GmbH. Latest innovations BioPharm: What are some of the latest innovati…

Article Continued Process Verification for Biopharma Manufacturing
CMC Biotech Working Group,A-Mab: a Case Study in Bioprocess Development(Oct. 30, 2009), accessed Sept. 16, 2014. 4. From presentation at 10th APIC/CEFIC meeting, “FDA’s Quality Initiatives—An Upda…

Article Application of Quality by Design to Viral Safety
40-47  The biotech industry has begun to implement a quality-by-design (QbD) approach to ensure the quality of biopharmaceuticals. Using this approach, products are developed with a thorough under…

Article Healthcare Reform in China
Companies can also explore the option of collaborating with partners in China or teaming with local biotech companies and research institutes. In addition, opportunities can be found in the generi…

Article Q&As with Industry Leaders
Karol Lacki, Customer Collaborations Leader, Cytiva The Role of HIC in Biotech Professor Alois Jungbauer, Department of Biotechnol…

Article Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions
The Chimigen HBV vaccine is in late pre-clinical development, having achieved ex vivo proof of concept and is ready for out-licensing to a pharmaceutical/biotech partner for clinical development, acco…

Article Manufacturers Struggle with Breakthrough Drug Development
The designation also plays well on Wall Street, which is particularly important for smaller biotech companies. As of Jan. 31, 2014, manufacturers submitted 140 requests for breakthrough statu…

Previous PageNext Page